CXCR3 and hepatocellular carcinoma: IRF1 was found to regulate C-X-C motif chemokine 10 (CXCL10)/chemokine receptor 3 (CXCR3) signaling axis, thereby further activating antitumor immunity in hepatocellular carcinoma (HCC).